Results 251 to 260 of about 149,441 (296)
Growth hormone-releasing hormone in retinal disorders and uveitis: an updated review. [PDF]
Yi SL, Huang YQ.
europepmc +1 more source
The therapeutic potential of local injection of leptin for periodontitis in rats: an investigation based on the OPG/RANKL mechanism. [PDF]
Guo Z, Hu Q, Li H, Liu N, Liu Q.
europepmc +1 more source
Trigeminal ganglion interferon-γ signaling drives orofacial neuropathic pain in rats. [PDF]
Kobayashi M +10 more
europepmc +1 more source
INTRAARTICULAR EXPRESSION OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN BY EXVIVO GENE-TRANSFER
Bandara, G +8 more
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein
Joint Bone Spine, 2014Erdheim-Chester disease is a rare non-langerhans systemic histiocytosis of unknown origin, associated with bone diseases and severe visceral complications. Therapies have been disappointing. A recombinant form of interleukin-1 receptor antagonist (anakinra) has been used in a few cases when usual treatment fails.
Roland Chapurlat
exaly +3 more sources
Cytokine, 2000
Hypoxic pulmonary vasoconstriction is associated with but may not be sufficient for the development of high-altitude pulmonary oedema (HAPO). Hypoxia is known to induce an inflammatory response in immune cells and endothelial cells. It has been speculated that hypoxia-induced inflammatory cytokines at high altitude may contribute to the development of ...
Günther Hartmann, M Toepfer
exaly +3 more sources
Hypoxic pulmonary vasoconstriction is associated with but may not be sufficient for the development of high-altitude pulmonary oedema (HAPO). Hypoxia is known to induce an inflammatory response in immune cells and endothelial cells. It has been speculated that hypoxia-induced inflammatory cytokines at high altitude may contribute to the development of ...
Günther Hartmann, M Toepfer
exaly +3 more sources
Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells
European Journal of Immunology, 1993AbstractA naturally occurring receptor‐level antagonist of interleukin‐1 (IRAPorIL‐1 ra) has recently been cloned. To determine what stimuli might regulate this inhibitor, cytokines were tested for their effects on the steady‐state level of IRAP mRNA in phorbol ester‐differentiated U937 cells.
A E Berger, D B Carter
exaly +3 more sources
Treatment With an Interleukin-1 Receptor Antagonist Protein Prolongs Mouse Islet Allograft Survival
Diabetes, 1993An interleukin-1 receptor antagonist protein was evaluated with regard to its efficacy in allogeneic and xenogeneic islet transplantation. Alloxan-induced diabetic C57BL/6 (H-2b) mice were transplanted under the kidney capsule with 500 C57BL/Ks (H-2d) mouse islets.
J -O Sandberg +2 more
exaly +4 more sources

